Myrbetriq (Mirabegron) is a prescription medication for adults used to treat certain bladder problems (overactive bladder, neurogenic detrusor overactivity). Mirabegron is a type of medicine called a beta-3-adrenergic-receptor agonist, an alternative OAB treatment to antimuscarinics. It works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder. Other alternative drugs include Vesicare, Ditropan, Toviaz.
In a study (A Prospective, Randomized, Placebo-Controlled Pilot Study of Mirabegron (Myrbetriq) and Behavioral Modification for Overactive Bladder in Parkinson Disease (908), April 14, 2020), P Agarwal, T Brown, S Ray, A Madan, I Roy-Faderman, found that “Mirabegron was safe and well-tolerated in this PD (Parkinson disease) population.”
In another clinical trial (STOMp: sexual function trial of overactive bladder medication, January 12, 2023), Allison Polland, MD, found that “Female sexual function has been shown to improve with overactive bladder (OAB) treatment”.
We have the brand Myrbetriq manufactured by Astellas Pharma from Canada, Turkey, and the United Kingdom. It is available in the strength of 25 mg and 50 mg. Generic Mirabegron comes from India manufactured by Sun Pharma, it is also known as Mirago.
Common side effects include:
• Fast heartbeat;
Serious side effects include:
• Itching/swelling (especially of the face/tongue/throat);
• Severe dizziness;
• Trouble breathing
Before you take Mirabegron, inform your doctor or pharmacist if you are allergic to it or if you have any other allergies. Inform your doctor if you have liver or kidney problems. This medication may contain inactive ingredients, which can cause allergic reactions or other problems. Myrbetriq can increase blood pressure. Hypertensive patients should check their blood pressure regularly. This medication may increase your chances of not being able to empty your bladder. Inform your doctor right away if you have trouble emptying your bladder or you have a weak urine stream. This medication may make you dizzy. Do not drive, use machinery, or do any activity that requires alertness until you are sure you can perform such activities safely. Limit alcoholic beverages. Tell your doctor about all the medications you take including other medications for overactive bladder, especially thioridazine, lecainide, propafenone, digoxin, or solifenacin succinate. Myrbetriq may affect the way other medicines work, and other medicines may affect how Myrbetriq works.
Store Myrbetriq tablets at room temperature between 20°C to 25°C (68°F to 77°F). Keep the bottle closed. Discard unused portion after 28 days. It is not recommended to use Myrbetriq during pregnancy unless the potential benefit to the patient outweighs the risks. There are no adequate studies about the safety of Mirabegron when breastfeeding. Talk to your doctor if you are pregnant or breastfeeding.
* Is there a Myrbetriq coupon or savings program?
Unfortunately, there is no coupon or savings program available from our Canadian Pharmacy. However, you may visit myrbetriq.com for the cost saving program.
* How can I get a prescription for Myrbetriq?
Please get a prescription from your physician or a qualified healthcare professional provider.
* How long does it take for Myrbetriq to start working?
You may expect to see the results in 4 to 8 weeks. Mirabegron starts to work after about 3 to 4 hours.
* Is Myrbetriq covered by my insurance?
No, we do not accept any insurances.
* Will Myrbetriq cause weight gain?
Changes in weight or appetite weren’t reported in clinical studies of Myrbetriq. It may cause temporary weight gain as Myrbetriq can sometimes cause urinary retention (being unable to empty your bladder). Source